These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 7932632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
    Brenner BG, McCrea EL, Margolese RG.
    Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B, Lebow LT, Bradley TP.
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stimulation of a cell-mediated cytotoxic response to FeLV-induced T cell lymphomas in the cat.
    Tompkins MB, Tompkins WA.
    J Immunol; 1985 Oct; 135(4):2817-23. PubMed ID: 2993416
    [Abstract] [Full Text] [Related]

  • 10. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
    Klingemann HG, Wong E, Maki G.
    Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
    [Abstract] [Full Text] [Related]

  • 11. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G, Spuzić I.
    Srp Arh Celok Lek; 1995 May; 123(9-10):227-31. PubMed ID: 17974436
    [Abstract] [Full Text] [Related]

  • 12. A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro.
    Faraoni I, Cottarelli A, Giuliani A, Bonmassar L, Rossi L, Bonmassar E.
    J Immunol Methods; 2005 Oct 30; 305(2):162-72. PubMed ID: 16165149
    [Abstract] [Full Text] [Related]

  • 13. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL, Weaver AM, Brinckerhoff LH, Deacon DH, Gonias SL, Slingluff CL.
    J Immunother; 1998 Mar 30; 21(2):85-94. PubMed ID: 9551359
    [Abstract] [Full Text] [Related]

  • 14. Differences in non-MHC restricted cytotoxic activities of human peripheral blood lymphocytes after transfusion with allogeneic leukocytes or platelets possessing class I and/or class II MHC molecules.
    Pócsik E, Mihalik R, Réti M, Gyódi E, Pálóczi K, Mayer K, Kassai M, Herold M, Huber C, Petrányi GG.
    Immunobiology; 1990 Dec 30; 182(1):22-31. PubMed ID: 1983002
    [Abstract] [Full Text] [Related]

  • 15. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S, Hirabayashi H, Schwartz DR, Toso JF, Johnson JT, Herberman RB, Whiteside TL.
    Cancer Res; 1993 Mar 15; 53(6):1461-8. PubMed ID: 8443824
    [Abstract] [Full Text] [Related]

  • 16. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S, Bochennek K, Huenecke S, Zimmermann SY, Kuçi S, Müller T, Wels WS, Klingebiel T, Esser R, Koehl U.
    J Immunol Methods; 2007 Aug 31; 325(1-2):140-7. PubMed ID: 17663991
    [Abstract] [Full Text] [Related]

  • 17. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Cannon MJ, Parham GP.
    Am J Obstet Gynecol; 2000 Sep 31; 183(3):601-9. PubMed ID: 10992180
    [Abstract] [Full Text] [Related]

  • 18. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 19. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes.
    Rabinowich H, Cohen R, Bruderman I, Steiner Z, Klajman A.
    Cancer Res; 1987 Jan 01; 47(1):173-7. PubMed ID: 3491673
    [Abstract] [Full Text] [Related]

  • 20. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD, Economou JS, Shau H, Golub SH.
    J Surg Res; 1993 Nov 01; 55(5):486-92. PubMed ID: 8231167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.